By G HossainPosted on September 17, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Novartis stands alongside Big Pharma peers that have similarly invested in technologies to penetrate the blood-brain barrier, including GSK, Roche and Eli Lilly. Novartis drops $125M for Sironax’s tech to cross blood-brain barrier Post navigation Roche bets up to $1B to advance next-gen bispecifics with DualitasAfter Novartis’ devastating M&A losses, long live the executive willing to try